The Evolving Landscape of Non-Clear Cell Renal Cell Carcinoma

home / investigator-perspectives / the-evolving-landscape-of-non-clear-cell-renal-cell-carcinoma

Expert Dr. Elizabeth Plimack discusses the evolving treatment landscape of non-clear cell RCC.

Video 1 - "Overview of Non-Clear Cell Renal Cell Carcinoma"

EP. 1: Overview of Non-Clear Cell Renal Cell Carcinoma

March 5th 2024

Dr. Plimack provides a brief overview of the prevalence of non-clear cell renal cell carcinoma and a short description of their subtypes.

Watch

Video 2 - "KEYNOTE B61 Extended Follow Up of Lenvatinib plus Pembrolizumab in nccRCC 1L"

EP. 2: KEYNOTE B61 Extended Follow Up of Lenvatinib plus Pembrolizumab in nccRCC 1L

March 12th 2024

An expert discusses key data points from the KEYNOTE B61 extended follow up of Lenvatinib plus pembrolizumab in first line setting in non-clear cell renal cell carcinoma.

Watch

Video 3 - "Phase 2 Nivo/Cabo in Non-Clear Cell Renal Cell Carcinoma"

EP. 3: Phase 2 Nivo/Cabo in Non-Clear Cell Renal Cell Carcinoma

March 19th 2024

Elizabeth Plimack, MD discusses recent results from the phase 2 nivolumab and cabozantinib trial in nccRCC.

Watch

Video 4 - "Unmeet Needs in Non-Clear Cell Renal Cell Carcinoma"

EP. 4: Unmeet Needs in Non-Clear Cell Renal Cell Carcinoma

March 26th 2024

Dr. Plimack shares her insights on some unmeet needs and challenges when treating non-clear cell renal cell carcinoma.

Watch